Boxer Capital, LLC Buys Spark Therapeutics Inc, Immunomedics Inc, Amicus Therapeutics Inc, Sells Biogen Inc, uniQure NV, Allakos Inc

• New Purchases: ONCE, FOLD, ARGX, MRSN, KDMN, IDYA, AKRO, LJPC, VYGR, CLRB,
• Added Positions: IMMU, ODT, DBVT, MDCO,
• Reduced Positions: QURE, ALLK,
• Sold Out: BIIB,

For the details of Boxer Capital, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/boxer+capital%2C+llc/current-portfolio/portfolio

1. Mirati Therapeutics Inc (MRTX) - 1,715,560 shares, 16.58% of the total portfolio.
2. Odonate Therapeutics Inc (ODT) - 3,363,377 shares, 11.58% of the total portfolio. Shares added by 12.91%
3. BeiGene Ltd (BGNE) - 900,000 shares, 10.47% of the total portfolio.
4. Immunomedics Inc (IMMU) - 6,567,000 shares, 8.55% of the total portfolio. Shares added by 60.17%
5. Spark Therapeutics Inc (ONCE) - 600,000 shares, 5.76% of the total portfolio. New Position

Boxer Capital, LLC initiated holding in Spark Therapeutics Inc. The purchase prices were between $97.7 and $114.01, with an estimated average price of $107.99. The stock is now traded at around $101.00. The impact to a portfolio due to this purchase was 5.76%. The holding were 600,000 shares as of .

Boxer Capital, LLC initiated holding in Amicus Therapeutics Inc. The purchase prices were between $10.96 and $14.4, with an estimated average price of $12.68. The stock is now traded at around $10.25. The impact to a portfolio due to this purchase was 2.72%. The holding were 2,325,000 shares as of .

Boxer Capital, LLC initiated holding in argenx SE. The purchase prices were between $115 and $141.58, with an estimated average price of $126.95. The stock is now traded at around $137.04. The impact to a portfolio due to this purchase was 2.66%. The holding were 200,000 shares as of .

Boxer Capital, LLC initiated holding in Mersana Therapeutics Inc. The purchase prices were between $3.84 and $6.4, with an estimated average price of $4.71. The stock is now traded at around $2.73. The impact to a portfolio due to this purchase was 0.79%. The holding were 2,084,000 shares as of .

Boxer Capital, LLC initiated holding in Akero Therapeutics Inc. The purchase prices were between $18.08 and $19.83, with an estimated average price of $18.95. The stock is now traded at around $28.56. The impact to a portfolio due to this purchase was 0.71%. The holding were 396,695 shares as of .

Boxer Capital, LLC initiated holding in Kadmon Holdings Inc. The purchase prices were between $1.65 and $2.9, with an estimated average price of $2.23. The stock is now traded at around $2.63. The impact to a portfolio due to this purchase was 0.71%. The holding were 3,688,100 shares as of .

Boxer Capital, LLC added to a holding in Immunomedics Inc by 60.17%. The purchase prices were between $11.98 and $18.86, with an estimated average price of $15.07. The stock is now traded at around $14.15. The impact to a portfolio due to this purchase was 3.21%. The holding were 6,567,000 shares as of .

Boxer Capital, LLC added to a holding in DBV Technologies SA by 26.19%. The purchase prices were between $7.58 and $10, with an estimated average price of $8.94. The stock is now traded at around $9.32. The impact to a portfolio due to this purchase was 0.85%. The holding were 5,300,000 shares as of .

Boxer Capital, LLC added to a holding in The Medicines Co by 25.00%. The purchase prices were between $27.53 and $37.25, with an estimated average price of $32.61. The stock is now traded at around $32.86. The impact to a portfolio due to this purchase was 0.51%. The holding were 750,000 shares as of .

Boxer Capital, LLC sold out a holding in Biogen Inc. The sale prices were between $219.29 and $241.72, with an estimated average price of $230.78.